Plain-English translation of NCT06975384 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This study is exploring how sleep disturbance—trouble falling asleep, staying asleep, or poor sleep quality—may affect how well immune checkpoint inhibitors (a type of immunotherapy that helps your body fight cancer) and other lung cancer treatments work for you. Researchers want to understand if sleep problems are linked to how well these treatments control your cancer and how you do over time. They're following patients with different types of lung cancer—some advanced, some early-stage—to gather real-world information about this connection.
Sleep problems are common in people with cancer, but doctors don't fully understand how they might affect treatment success or survival. This study aims to fill that gap by examining whether better sleep or treating sleep problems could help this treatment work more effectively.
You likely qualify if…
You likely don't qualify if…
You will continue receiving your regular lung cancer treatment (such as immunotherapy or targeted therapy) from your doctor. As part of the study, you will be asked to fill out questionnaires about your sleep quality and how you're feeling at regular visits, usually while you're already coming in for your cancer care. The study team will also review your medical records to track how well your treatment is working and how your cancer progresses over time. The length of participation varies depending on which group you're in, but generally you'll be followed for several months to years as part of routine cancer monitoring.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China